Menu Search
Equities

Akso Health Group

8HX:BER

Akso Health Group

Actions
  • Price (EUR)1.00
  • Today's Change-0.04 / -3.85%
  • Shares traded--
  • 1 Year change+3.63%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 16:42 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Akso Health Group's revenues fell -81.68% from 13.18m to 2.41m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 1.36m to a larger loss of 9.46m.
Gross margin5.06%
Net profit margin-377.61%
Operating margin-357.78%
Return on assets-11.22%
Return on equity-12.32%
Return on investment-12.40%
More ▼

Cash flow in USDView more

In 2024, Akso Health Group increased its cash reserves by 837.75%, or 77.01m. Cash Flow from Financing totalled 131.65m or 5,452.99% of revenues. In addition the company generated 1.35m in cash from operations while cash used for investing totalled 54.72m.
Cash flow per share-0.1933
Price/Cash flow per share--
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in USDView more

Akso Health Group has a strong Balance Sheet and has consistently grown its cash reserves over the last four years to total 85.17m.
Current ratio39.52
Quick ratio39.46
Total debt/total equity0.0145
Total debt/total capital0.0142
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.